Cancer biomarkers and their biosensors: A comprehensive review
The article starts with a brief history of discovery of cancer biomarkers followed by statistical
data on published cancer biomarkers detection strategies in the last decade to demonstrate …
data on published cancer biomarkers detection strategies in the last decade to demonstrate …
Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods
S Jordaens, K Zwaenepoel, W Tjalma… - … Journal of Cancer, 2023 - Wiley Online Library
The aim of this review was to explore the status of urine sampling as a liquid biopsy for
noninvasive cancer research by reviewing used preanalytical parameters and protocols. We …
noninvasive cancer research by reviewing used preanalytical parameters and protocols. We …
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
Serum CA 19‐9 is the only FDA approved biomarker recommended for use in the routine
management of pancreatic ductal adenocarcinoma (PDA). Over 2,000 biomarker studies …
management of pancreatic ductal adenocarcinoma (PDA). Over 2,000 biomarker studies …
[HTML][HTML] A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study
S Debernardi, H O'Brien, AS Algahmdi, N Malats… - PLoS …, 2020 - journals.plos.org
Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with
around 9% of patients surviving> 5 years. Asymptomatic in its initial stages, PDAC is mostly …
around 9% of patients surviving> 5 years. Asymptomatic in its initial stages, PDAC is mostly …
3D plasmonic coral nanoarchitecture paper for label-free human urine sensing and deep learning-assisted cancer screening
Practical human biofluid sensing requires a sensor device to differentiate patients from the
normal group with high sensitivity and specificity. Label-free molecular identification from …
normal group with high sensitivity and specificity. Label-free molecular identification from …
Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine
Pancreatic ductal adenocarcinoma (PDAC) is a particularly challenging cancer, with very
low 5-year survival rates. This low survival rate is linked to late stage diagnosis, associated …
low 5-year survival rates. This low survival rate is linked to late stage diagnosis, associated …
[HTML][HTML] Liquid biopsy in pancreatic cancer: Are we ready to apply it in the clinical practice?
V Heredia-Soto, N Rodríguez-Salas, J Feliu - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the tumors with the
highest mortality, for which survival has hardly changed in the last 40 years. This high …
highest mortality, for which survival has hardly changed in the last 40 years. This high …
Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive
Pancreatic cancer is the fourth leading cause of cancer-related death in the United States.
There has been minimal progress with regard to cancer-specific outcomes in recent …
There has been minimal progress with regard to cancer-specific outcomes in recent …
NMR metabolomics of human blood and urine in disease research
This paper reviews the main applications of NMR metabolomics of blood and urine in
disease research, over the last 5 years. The broad range of disease types addressed attests …
disease research, over the last 5 years. The broad range of disease types addressed attests …
Analysis of bacterial biofilms using NMR-based metabolomics
Infectious diseases can be difficult to cure, especially if the pathogen forms a biofilm. After
decades of extensive research into the morphology, physiology and genomics of biofilm …
decades of extensive research into the morphology, physiology and genomics of biofilm …